Clinical trial Recruiting at 1 site Interventional Ages 55 to 80

CSF Flow MRI to aid diagnosis and prognosis in normal pressure hydrocephalus

Official title: Analysis of Cerebrospinal Fluid Dynamics in Patients With Normal Pressure Hydrocephalus Using Magnetic Resonance Imaging

Run by Chungnam National University Hospital · NCT07831044 · Data updated 2026-11-12

We’re testing if MRI measurements of CSF flow can help diagnose normal pressure hydrocephalus and predict how patients will respond to CSF drainage.

More Normal Pressure Hydrocephalus trials

Quick facts

Study typeInterventional
Ages55 Years to 80 Years
SexAll
Enrollment22 (estimated)
SponsorChungnam National University Hospital
Academic / other
Locations1 site (Daejeon, Jung-gu)
StatusRecruiting
StartedSeptember 11, 2025
Main results expectedDecember 2027
Study endsDecember 2028
Registry record updatedSeptember 21, 2026
Trial IDNCT07831044 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults with gait disturbance plus cognitive impairment and/or urinary dysfunction, with Evans' ratio ≥ 0.3 on MRI.

Probably not a fit

Patients with contraindications to lumbar puncture or MRI, or those with other neurological conditions that mimic gait disturbance, may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study uses phase-contrast MRI to measure cerebrospinal fluid flow dynamics in people with suspected normal pressure hydrocephalus. It will compare CSF flow parameters before and after CSF drainage procedures to see how changes relate to clinical improvement. The goal is to see whether these imaging biomarkers can improve diagnostic confidence and prognostic predictions. The study is observational in terms of imaging analysis and assesses associations with patient symptoms and outcomes.

Why it matters

Potential benefit: If successful, MRI CSF flow metrics could improve accuracy of NPH diagnosis and help guide treatment decisions.

How similar studies have gone: Prior research suggests CSF flow measurements can reflect CSF dynamics; this approach has been explored but is not yet standard practice for NPH prognosis.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients presenting with clinical symptoms consistent with normal pressure hydrocephalus (presence of gait disturbance accompanied by at least one of the following: cognitive impairment or urinary dysfunction)
* Evans' ratio ≥ 0.3 on brain MRI

Exclusion Criteria:

* Patients who cannot undergo CSF drainage due to structural abnormalities of the lumbar spine
* Contraindications to lumbar puncture and CSF drainage (e.g., local infection at the puncture site, suspected elevated intracranial pressure, platelet count \< 40,000/µL, or coagulopathy)
* Coexisting neurological disorders that can also cause gait disturbance, such as Parkinson's disease, atypical parkinsonian syndromes, or vascular parkinsonism
* Contraindications to MRI (e.g., presence of cardiac pacemakers, implantable defibrillators, or other non-MRI-compatible implantable medical devices)

Where it's running

  • Chungnam National University Hospital
    Daejeon, Jung-gu, South Korea
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • White matter damage and dementia markers in normal pressure hydrocephalus

    This study tries to see if patterns of white matter damage, dementia-related biomarkers, wearable activity monitors, and digital cognitive tests can predict and track which older adults with normal pressure hydrocephalus will improve after CSF shunt surgery.

    Recruiting Imperial College London · London · NCT07103681

  • Evaluating outcomes in neurosurgery using standardized measures

    This study is trying to see how different factors affect the results of brain surgeries by collecting information from patients before and after their operations.

    Recruiting at 11 sites Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta · Bergamo, BG and 26 other locations · NCT06724029

  • Evaluating gait changes in patients with normal pressure hydrocephalus using smart insoles

    This study is testing if a CSF tap can improve walking and balance in people with normal pressure hydrocephalus by using smart insoles to track their movements.

    Recruiting Yonsei University · Yongin-si, Gyeonggi-do · NCT06722768

  • Comparing protein patterns in skin biopsies of neurodegenerative diseases

    This study is trying to see if the patterns of certain proteins in skin samples can help doctors better understand and diagnose different neurodegenerative diseases like Alzheimer's, Parkinson's, and frontotemporal dementia.

    Recruiting Universidad Autonoma de San Luis Potosí · San Luis Potosí City · NCT06528964

  • Investigating early signs of Normal Pressure Hydrocephalus

    This study is trying to see if special brain scans and tests on spinal fluid and blood can help predict how Normal Pressure Hydrocephalus develops in people who have early signs, those with symptoms, and healthy individuals over five years.

    Recruiting at 2 sites Uppsala University Hospital · Kuopio and 6 other locations · NCT05910944

  • Sleep apnea and how it affects shunts in normal-pressure hydrocephalus

    This project will measure intracranial and intra-abdominal pressures during sleep in people with normal-pressure hydrocephalus to see if sleep apnea affects shunt function and whether treating sleep apnea improves symptoms.

    Recruiting University of Valencia · Valencia, Valencia · NCT04471740

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.